Determination of melagatran, a novel, direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry.
- 1 January 2002
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 766 (1) , 47-55
- https://doi.org/10.1016/s0378-4347(01)00429-7
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Simultaneous determination of a novel thrombin inhibitor and its two metabolites in human plasma by liquid chromatography/tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2000
- Determination of a novel thrombin inhibitor in human plasma and urine utilizing liquid chromatography with tandem mass spectrometric and ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- High-performance liquid chromatographic determination of a new oral thrombin inhibitor in the blood of rats and dogsJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic EnzymesThrombosis and Haemostasis, 1998
- Quantitation of an orally available thrombin inhibitor in rat, monkey and human plasma and in human urine by high-performance liquid chromatography and fluorescent post-column derivatization of arginineJournal of Chromatography A, 1997